A Study of the Immune Response to Vaccines and Ixekizumab (LY2439821) in Healthy Participants
Clinical trial NCT02543918 · COMPLETED
Trial details
- NCT number
- NCT02543918
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2015-11-01
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.